Arrevus Information

View Top Employees from Arrevus

Arrevus is a clinical-stage biotechnology company developing novel therapies for orphan diseases. Our mission is to develop therapeutics for unmet medical needs in areas with high treatment failure rates, few therapeutic options, and serious outcomes. Arrevus is advancing ARV-1801, a Phase III clinical program targeting cystic fibrosis pulmonary exacerbations. Arrevus is also advancing preclinical programs to address unmet needs in oncology and antimicrobial resistance.

Website	http://www.arrevus.com
Revenue	$9 million
Funding	$1 million
Employees	3 (0 on RocketReach)
Founded	2017
Address	2 Davis Dr, Durham, North Carolina 27709, US
Phone	+1 919-588-3727
Technologies	JavaScript , HTML , PHP +19 more (view full list)
Industry	Biotechnology, Biotechnology Research, Pharmaceuticals, Healthcare, Science and Engineering, Drug Manufacturing & Research, Pharmaceutical, Health Care
Keywords	Biotechnology, Orphan Diseases, Rare Diseases, Therapeutics, Novel Therapies, Therapeutic Development, Clinical Stage, Drug Development, Unmet Medical Needs, Drug Discovery, Biotechnology Research, Pharmaceutical, Treatment Options, Clinical Trials, Life Sciences, Biopharmaceutical, Medical Research, Pharmaceutical Research
Competitors	Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, GSK, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen +43 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies